Product Information
ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) is a generic product labeled by Cameron Pharmaceuticals, priced at $2.5539 per ML under NDC 42494043525. Its NADAC has been published 34 times since Feb 11, 2026.
FDA first approved this application on Mar 14, 2025. Its Orange Book therapeutic-equivalence code is AN.
Strength
100 mg/mL
Manufacturer
Cameron PharmaceuticalsNDC
42494043525
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA214177FDA Approved
3/14/2025
TE Code
AN
On Market Since
8/21/2025
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) has been published 34 times since Feb 11, 2026, and over the history we have for it it has risen 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5539 per ML |
|---|---|
| All-time high | $2.6433 (Aug 12, 2026) |
| All-time low | $2.3268 (Feb 11, 2026) |
| 52-week high | $2.6433 |
| 52-week low | $2.3268 |
| Median price | $2.5569 |
| Average price | $2.5312 |
| Largest weekly change | +5.1% (Apr 22, 2026) |
| Weeks tracked | 34 |
| Tracking since | Feb 11, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cameron Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetylcysteine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antidote class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION), manufactured by Cameron Pharmaceuticals, is $2.5539 per ML (NDC 42494043525), effective Sep 30, 2026.
How has the price of ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) has risen 9.8%. It has been tracked across 34 weekly CMS publications since Feb 11, 2026.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)?
Since Feb 11, 2026, the NADAC for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) has ranged from a low of $2.3268 (Feb 11, 2026) to a high of $2.6433 (Aug 12, 2026), with a median of $2.5569 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) in a comparable dosage form, but none are currently priced below it.
Who manufactures ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) (NDC 42494043525) is labeled by Cameron Pharmaceuticals, and CMS classifies it as a generic product.